menu
    • menu

    Company profile for Shanghai Henlius Biotech

    NEW Drugs in Dev: 53
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a global biopharmaceutical company focusing on oncology and auto-immune diseases with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide. Founded in 2010 and headquartered in Shanghai, we have built three global R&D facilities in Shanghai, Taipei and California collaborating with each other to ensure the highly productive and cost-efficient R&D processes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shanghai Henlius BiotechChina Flag
    Country
    Country
    China
    Address
    Address
    9/F, Innov Tower, Zone A, No. 1801 Hongmei Road, Xuhui District, Shanghai
    Telephone
    Telephone
    021-33395800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.henlius.com/en/Index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    European Commission (EC) Approves Henlius And Organon's Poherdy
    European Commission (EC) Approves Henlius And Organon's Poherdy

    29 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-commission-ec-approves-henlius-and-organons-poherdy-pertuzumab-the-first-approved-biosimilar-to-perjeta-pertuzumab-in-europe-302757076.html

    PR NEWSWIRE
    29 Apr 2026
    Share Share
    Alligator Bioscience Reacts To Henlius' HLX49 Preclinical Data
    Alligator Bioscience Reacts To Henlius' HLX49 Preclinical Data

    23 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-23/alligator-bioscience-comments-on-henlius-presentation-of-hlx49-preclinical-data-at-aacr-2026

    PHARMIWEB
    23 Apr 2026
    Share Share
    Eisai, Henlius Ink Exclusive Deal For Anti-PD-1 Antibody In Japan
    Eisai, Henlius Ink Exclusive Deal For Anti-PD-1 Antibody In Japan

    05 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-and-henlius-enter-into-exclusive-commercial-license-agreement-for-anti-pd-1-antibody-serplulimab-in-japan-302680135.html

    PR NEWSWIRE
    05 Feb 2026
    Share Share
    At JPM 2026, Henlius Showcases
    At JPM 2026, Henlius Showcases "Globalisation 2.0" Strategy

    16 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/henlius-showcases-globalisation-2-0-strategy-and-mid-to-long-term-innovation-blueprint-at-jpm-2026--302663383.html

    PR NEWSWIRE
    16 Jan 2026
    Share Share
    Supply Chain Ties, Bayer Biotech Incubator—Fierce Pharma Asia
    Supply Chain Ties, Bayer Biotech Incubator—Fierce Pharma Asia

    21 Nov 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fierce-pharma-asia-us-china-supply-chain-ties-bayer-biotech-incubator-henlius-biosim-nod

    FIERCE PHARMA
    21 Nov 2025
    Share Share
    FDA Approves POHERDY® as First PERJETA Biosimilar
    FDA Approves POHERDY® as First PERJETA Biosimilar

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117955804/en/Henlius-and-Organon-Announce-US-FDA-Approval-of-POHERDY-pertuzumab-dpzb-the-First-PERJETA-pertuzumab-Biosimilar-in-the-US

    BUSINESSWIRE
    17 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Shanghai Henlius Biotech and get a quotation

    Shanghai Henlius Biotech is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find MANUFACTURING AND CONTROL OF RHUPH20 bulk with DMF offered by Shanghai Henlius Biotech

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search